Results 141 to 150 of about 290,304 (371)
Advanced NanoBiomed Research, EarlyView.Encapsulated acriflavine (ACF) and copper oxide nanoparticles (CuO NPs) are coreleased from coaxial nanofibers, producing synergistic antiglioblastoma multiforme effects. ACF suppresses the hypoxia‐inducible factor 1α pathway related to many downstream factors for tumor growth, while CuO NPs generate reactive oxygen species that assist cuproptosis ...
Daewoo Han +4 more
wiley +1 more source
Advanced NanoBiomed Research, EarlyView.This review explores how surface‐coated inorganic nanomaterials are chemically engineered for advanced drug delivery. It highlights design principles, coating strategies, and biomedical applications, emphasizing how surface chemistry governs biocompatibility, targeting, and controlled release.
Hossein Daneshgar +4 more
wiley +1 more source
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.
New England Journal of Medicine, 2004 H. Hurwitz +14 more
semanticscholar +1 more source
A New Era for Using Natural Pigments: The Case of the C50 Carotenoid Called Bacterioruberin
Biotechnology and Applied Biochemistry, EarlyView.ABSTRACT Haloarchaea are extremophilic microorganisms belonging to the Archaea domain that require high salt concentrations to live, thus inhabiting ecosystems like salty ponds, salty marshes, or extremely salty lagoons. They are more abundant and widely distributed worldwide than initially expected.
Micaela Giani +5 more
wiley +1 more source
Biotechnology and Applied Biochemistry, EarlyView.ABSTRACT Gastrointestinal cancers (GICs) constitute one of the leading causes of cancer‐related morbidity and mortality worldwide. Despite currently available therapeutic strategies, new approaches and procedures are needed for their prevention and treatment.
Raúl Vergara +5 more
wiley +1 more source
Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro [PDF]
, 2001 Gamal M. El Maghraby +2 more
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang +6 more
wiley +1 more source
International Journal of NanomedicineWenhui Zhang,1 Qiang Wang,2 Fengguo Zhai,1 Xingjun Fan,3 Fanqin Meng,1 Guangzhi Shen,1 Ying Zhu,1 Jingdan Cao,1 Fengbo Yu1 1School of Pharmacy, Mudanjiang Medical University, Mudanjiang, 157011, People’s Republic of China; 2Hongqi People Hospital ...
Zhang W +8 more
doaj
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
New England Journal of Medicine, 2004 T. André +11 more
semanticscholar +1 more source
BMEMat, EarlyView.Efficient drug delivery to the posterior segment of the eye has long been a challenging issue due to the complex ocular barriers. The review focuses on the promise held by nanoplatforms for barrier penetration and the key mechanisms involved, also highlighting their advantages in achieving efficient drug delivery and superior treatment of PSEDs ...
Yifan Shen +7 more
wiley +1 more source